Investing.com – U.S. stock futures rose on Monday as investors assessed reports that Washington and Tehran had agreed to halt recent hostilities around the Strait of Hormuz and resume diplomatic talks, easing fears of broader disruptions in the Middle East.
By 07:39 ET, S&P 500 Futures had gained 0.65%, Nasdaq 100 Futures had climbed 1.16%, and Dow Jones Futures had advanced 0.43%.
Technology and healthcare stocks led premarket gains, while investors also reacted to corporate restructuring announcements and analyst actions.
Here are some of the biggest premarket U.S. stock movers today:
Comcast shares surged 13% after the media and telecommunications company unveiled plans to spin off NBCUniversal and Sky into a separate publicly traded company. The tax-free transaction is expected to be completed within a year, with existing shareholders receiving stock in both companies.
Viridian Therapeutics climbed 10.2% after the U.S. Food and Drug Administration approved Lumvoa for the treatment of thyroid eye disease. The approval marks the company’s first commercial product and paves the way for an immediate U.S. launch.
SpaceX rose more than 1% after Nasdaq announced the aerospace company will join the Nasdaq-100 Index on July 7. The inclusion is expected to trigger buying from index-tracking funds and exchange-traded products.
Verizon Communications gained 1% after agreeing with BT Group to combine their international enterprise operations into a 50:50 joint venture serving more than 3,000 multinational customers across over 180 countries.
Doximity fell 5.1% as investor sentiment remained under pressure following a series of analyst price target cuts in the wake of weaker-than-expected fiscal 2027 revenue guidance issued last month.
Applied Aerospace and Defense gained 2.1% after several Wall Street firms initiated coverage of the recently listed defense manufacturer. Baird assigned an Outperform rating and the highest price target on the Street, citing favorable long-term defense spending trends.
Related articles
Comcast, Viridian Therapeutics jump premarket; Doximity slips
JPMorgan outlines ten strategic themes that could shape the outlook for 2026
Morgan Stanley CIO survey: Why AI hype isn’t boosting 2026 IT budgets
